Oct 5 – 7, 2026
Hotel Berlin, Berlin
Europe/Berlin timezone
>> Safe the date for the next symposium: September 29 – October 1, 2027 <<

Replication assessment of chimeric HEV-3 subtypes demonstrates enhanced replication fitness of HEV-3f isolates

Oct 5, 2026, 7:09 PM
1m
Area C

Area C

Poster presentation Novel and Emerging Pathogens Snacks & Poster Viewing I

Speaker

Alina Kohl

Description

Hepatitis E virus (HEV) remains an underestimated global health concern, causing an estimated 20 million infections and 3450 - 70,000 deaths annually. In Europe, genotype 3 (HEV-3) is the prevalent genotype, comprizing 15 subtypes organized in three clades: Clade 1 (3efg), Clade 2 (3abchijklmno) & Clade 3 (3ra). Infections with HEV 3 clade 1 have been associated with more severe disease outcomes, although the underlying mechanisms remain unclear.
We performed a phylogenetic analysis of HEV-3 subtypes and generated a library of 15 primary isolate-derived polymerase chimeras, each inserted into the backbone of the Kernow-C1 p6 subgenomic replicon. We evaluated replication kinetics and identified molecular determinants of HEV replication.
Phylogenetic analysis revealed considerable diversity among the HEV-3 polymerases, with up to 21 substitutions relative to p6. 13 of the 15 chimeras demonstrated replication comparable to the parental p6 construct. The HEV-3f subtype showed significantly enhanced replication kinetic, with up to a 5-fold increase after 24 h.
Our findings highlight the genomic flexibility of HEV-3, which allows for efficient replication of diverse chimeric constructs. This model provides a robust platform for assessing intra-genotypic variability in antiviral responses and advances our mechanistic understanding of replication fitness. Such insights are critical for optimising treatment strategies and understanding the burden of disease in HEV-infected patients.

Keywords

Hepatitis E, HEV, Viral hepatitis

Registration ID 128
Professional Status of the Speaker PhD Student
Junior Scientist Status Yes, I am a Junior Scientist.

Authors

Alina Kohl Dr Rui Marques Da Costa (1 Department for Molecular und Medical Medicine, Ruhr University Bochum, Germany ;2 Hepatitis E Virus Research Hub (HepE-Hub), Bochum, Germany)

Co-authors

Dr André Gömer (1 Department for Molecular und Medical Medicine, Ruhr University Bochum, Germany ;2 Hepatitis E Virus Research Hub (HepE-Hub), Bochum, Germany) Prof. Daniel Todt (1 Department for Molecular und Medical Medicine, Ruhr University Bochum, Germany; 2 Hepatitis E Virus Research Hub (HepE-Hub), Bochum, Germany; 3 Department of Translational and Computational Infection Research, Ruhr University Bochum, Germany) Prof. Eike Steinmann (1 Department for Molecular und Medical Medicine, Ruhr University Bochum, Germany ;2 Hepatitis E Virus Research Hub (HepE-Hub), Bochum, Germany) Dr Michelle Jagst (1 Department for Molecular und Medical Medicine, Ruhr University Bochum, Germany ;2 Hepatitis E Virus Research Hub (HepE-Hub), Bochum, Germany)

Presentation materials

There are no materials yet.

External references

Peer reviewing

Paper